Why the Althea (ASX:AGH) share price will be on watch today

The Althea Group Holdings Ltd (ASX: AGH) share price will be on watch this morning. This comes after the company announced that it signed a new supply and distribution agreement.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price will be on watch this morning. This comes after the company announced that it signed a supply and distribution agreement with a UK medical cannabis supplier.

At yesterday's close of market, the Althea share price finished the day at 43 cents.

little green pharma share price represented by cannabis leaf character jumping cheerfully

Image source: Getty Images

New agreement

Althea advised it has entered a contract with medicinal cannabis supplier Lyphe Group to supply and distribute its products in the United Kingdom, and the nearby island Jersey.

Under the terms, Althea will supply Lyphe with its medicinal cannabis products for non-exclusive distribution rights across the United Kingdom. Patients will have access to the products through The Medical Cannabis Clinics (TMCC). This will be dispensed through Lyphe's own pharmacy, Dispensary Green.

In Jersey, TMCC recently opened up, thus allowing Lyphe to establish a new distribution structure. Althea will grant Lyphe exclusive distribution rights for Jersey, where it seeks to support thousands of medicinal cannabis patients.

Subject to customary conditions, the deal is set for an initial 12 months, with the option to extend further.

What did both parties say?

Althea CEO Mr Josh Fegan commented on the new partnership:

The supply and distribution agreement with Lyphe Group is an important milestone in Althea's UK strategy, as the Company continues to increase its market share in the rapidly growing territory. The agreement with Lyphe Group creates supplementary growth for the Company, whilst further enhancing our brand awareness and standing in the marketplace. We look forward to the Althea brand continuing to have strong representation on Lyphe Group's formulary in the UK and Jersey.

Lyphe Group CEO, Mr Dean Friday added to Mr Fegan's comments:

It's hard to believe that a few months ago none of the patients in Jersey were able to obtain critical medical cannabis treatments, instead they were driven to the black market. Now, not only does LYPHE Group have an operating clinic on the island, TMCC Jersey, it also has a fantastic pharmacy partner in Reid's Pharmacy chain. We are pleased that Althea has come onboard with us as we work to ensure every patient has a consistent and affordable supply of medical cannabis.

About the Althea share price

The Althea share price has performed well over the past 12 months, rising by 22%.

The company's shares reached a multi-year low of 15 cents in March, and a 52-week high of 67 cents in September.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Broker Notes

Buy, hold, sell: Life360, Northern Star, and Sigma shares

Are these popular shares buys? Here's how analysts rate them.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

6 ASX All Ords shares elevated to strong buy status after March sell-off

The ASX All Ords fell 8% in March after the US and Israel attacked Iran and oil and gas prices…

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Market News

Why Beetaloo, Fortescue, Orora, and Whitehaven Coal shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Man in a business suit leaps off a boulder in front of a blue sky.
Share Gainers

3 ASX 200 stocks surging 13% to 36% in this shortened trading week

Investors sent these three ASX 200 stocks flying higher following the Easter break. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Amaero, Mesoblast, Telix, and Tivan shares are charging higher today

These shares are ending the week on a high. But why?

Read more »

A young couple stands next to a real estate agent in an empty apartment they are inspecting.
Real Estate Shares

Mirvac shares sink to their lowest level since 2015. Is this ASX property giant back on the radar?

Multi-year lows put Mirvac shares back on investors’ watchlists today.

Read more »